Hedy Lee Kindler, MD, shares new mesothelioma guidelines that have been released by the American Society of Clinical Oncology ...

Investing.com -- Shares of Portage Biotech Inc. (NASDAQ: PRTG) surged 29% following the presentation of new preclinical data for its mesothelioma treatment, PORT-7. The company unveiled these findings ...

After being used since the 1940s in various industries, asbestos is now linked to severe health risks, including asbestosis, ...

Biliary Tract Cancer (BTC): KEYTRUDA may be combined with chemotherapy medicines to treat BTC, a cancer that affects the bile ducts or gallbladder. This treatment is for adults when the cancer has ...

While cancer research has experienced significant developments in the past two decades, resulting in considerable improvements in survival rates, for some cancers, progress is painfully slow.  Most of ...

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...

Montana has a rich history of asbestos mining and use. In this state, the Environmental Protection Agency declared for the ...

Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, presented new preclinical data ...